Citation 1107

ITO,A: SHAMON,LA: YU,BY: MATA-GREENWOOD,E: LEE,SK: VAN BREEMEN,RB: MEHTA,RG: FARNSWORTH,NR: FONG,HHS: PEZZUTO,JM: KINGHORN,AD:. (1998). ANTIMUTAGENIC CONSTITUENTS OF CASIMIROA EDULIS WITH POTENTIAL CANCER CHEMOPREVENTIVE ACTIVITY.. 46(9)

Citation Details

TitleANTIMUTAGENIC CONSTITUENTS OF CASIMIROA EDULIS WITH POTENTIAL CANCER CHEMOPREVENTIVE ACTIVITY.
AuthorsITO,A: SHAMON,LA: YU,BY: MATA-GREENWOOD,E: LEE,SK: VAN BREEMEN,RB: MEHTA,RG: FARNSWORTH,NR: FONG,HHS: PEZZUTO,JM: KINGHORN,AD:
Year1998
Volume46
Issue9

Summary

Year: 1998

Journal: Unknown

Organisms and Their Experiments (1)

Casimiroa edulis (RUTACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified
VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OFCMR SPECTRUM REPORTEDQUANTITATIVE DATA
PHELLOPTERIN
None
2
ANTIMUTAGENIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
PHELLOPTERIN
ACTIVE
3Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
PIMPINELLIN,ISO:
None
4
ANTIMUTAGENIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
PIMPINELLIN,ISO:
ACTIVE
5Not specified
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
PSORALEN,5-METHOXY-8-[(6-7-DIHYDROXY-3-7-DIMETHYL-OCT-2-ENYL)-OXY]: (R,S):
None
6Not specified
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
PSORALEN,8-[(6-7-DIHYDROXY-3-7-DIMETHYL-OCT-2-ENYL)-OXY]:
None
7
ANTIMUTAGENIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
PSORALEN,8-[(6-7-DIHYDROXY-3-7-DIMETHYL-OCT-2-ENYL)-OXY]:
WEAK ACTIVITY
8Not specified
ISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA
CASIMIROIN
None
9
ANTIMUTAGENIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
CASIMIROIN
ACTIVE
10Not specified
IDENTIFICATION OFPHARMACOLOGY OF COMPOUND - IN VITRO
CASIMIROIN
ACTIVE
11Not specified
ISOLATION AND IDENTIFICATION OFCMR SPECTRUM REPORTEDQUANTITATIVE DATA
QUINOLIN-2(1H)-ONE,4-METHOXY-1-METHYL:
None
12
ANTIMUTAGENIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
QUINOLIN-2(1H)-ONE,4-METHOXY-1-METHYL:
WEAK ACTIVITY
13Not specified
ISOLATION AND IDENTIFICATION OFCMR SPECTRUM REPORTEDQUANTITATIVE DATA
QUINOLIN-4-ONE,5-HYDROXY-1-METHYL-2-PHENYL:
None
14
ANTIMUTAGENIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
QUINOLIN-4-ONE,5-HYDROXY-1-METHYL-2-PHENYL:
ACTIVE
15Not specified
ISOLATION AND IDENTIFICATION OFCMR SPECTRUM REPORTEDQUANTITATIVE DATA
FAGARINE,GAMMA:
None
16Not specified
ISOLATION AND IDENTIFICATION OFCMR SPECTRUM REPORTEDQUANTITATIVE DATA
ZAPOTIN
None
17
ANTIMUTAGENIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
ZAPOTIN
INACTIVE
18Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
FLAVONE,2'-5-6-TRIMETHOXY:
None
19
ANTIMUTAGENIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
FLAVONE,2'-5-6-TRIMETHOXY:
ACTIVE
20
CYTOCHROME OXIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
FLAVONE,2'-5-6-TRIMETHOXY:
ACTIVE
Show SPARQL Queries (1)